跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
CCP-RIZATRIPTAN ODT
Authorized
STANDARD
CCP-RIZATRIPTAN ODT
cellchem pharmaceuticals inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ea367875b56f75f4
Company
cellchem pharmaceuticals inc.
Type
Standard
Approval Details
Approval Id
ea367875b56f75f4
Drug Approval Canada Name
CCP-RIZATRIPTAN ODT
Product Name
CCP-RIZATRIPTAN ODT
Status
Cancelled Post Market
Status Date
2023-08-03
Original Market Date
2019-01-04
Din
02458772
Drug Class
Human
Dosage Form
Tablet (Orally Disintegrating)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:32.28
Atc Original
N02CC04 RIZATRIPTAN
Atc Name
n 02 cc 04
Aig Number
0137841002
Company Name
cellchem pharmaceuticals inc.
Company Address
UNIT 1, 30 Concourse Gate, Ottawa, Ontario, Canada, K2E 7V7
Active Ingredients
RIZATRIPTAN (RIZATRIPTAN BENZOATE)
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ea367875b56f75f4
Type
Standard
Back to Health Canada Approvals